1. [1] Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, Zhang LJ. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology 2020; 200490. [DOI:10.1148/radiol.2020200490] [PMID] [PMCID]

2. [2] MacKenzie D. Covid-19 goes global. Elsevier; 2020. [DOI:10.1016/S0262-4079(20)30424-3]

3. [3] Coronavirus disease (COVID-19) outbreak, Situation Report-86 WHO; 2020 [March 8]; Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.

4. [4] Tuite AR, Bogoch I, Sherbo R, Watts A, Fisman DN, Khan K. Estimation of COVID-2019 burden and potential for international dissemination of infection from Iran. Med Rxiv 2020. [DOI:10.1101/2020.02.24.20027375]

5. [5] Chen D, Zhou T. Control Efficacy on COVID-19. ArXiv preprint arXiv: 200300305 2020.

6. [6] Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, James L, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003; 300: 1966-1970. [DOI:10.1126/science.1086616] [PMID] [PMCID]

7. [7] Lipsitch M, Swerdlow DL, Finelli L. Defining the epidemiology of Covid-19-studies needed. N E J Med 2020; 382: 1194-1196. [DOI:10.1056/NEJMp2002125] [PMID]

8. [8] Gilbert M, Pullano G, Pinotti F, Valdano E, Poletto C, Boëlle PY, et al. Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study. The Lancet 2020; 395: 871-877. [DOI:10.1016/S0140-6736(20)30411-6]

9. [9] Peng L, Yang W, Zhang D, Zhuge C, Hong L. Epidemic analysis of COVID-19 in China by dynamical modeling. arXiv preprint arXiv:200206563 2020. [DOI:10.1101/2020.02.16.20023465]

10. [10] Castillo-Chavez C, Feng Z, Huang W. On the computation of ro and its role on. Mathematical approaches for emerging and reemerging infectious diseases: an introduction. 2002; 1: 229. [DOI:10.1007/978-1-4757-3667-0_13]

11. [11] Blackwood JC, Childs LM. An introduction to compartmental modeling for the budding infectious disease modeler. Lett Biomath 2018; 5: 195-221. [DOI:10.30707/LiB5.1Blackwood]

12. [12] Chen S, Yang J, Yang W, Wang C, Bärnighausen T. COVID-19 control in China during mass population movements at New Year. The Lancet 2020; 395: 764-766. [DOI:10.1016/S0140-6736(20)30421-9]

13. [13] Giesecke J. Modern infectious dsisease epidemiology. second ed. London: Arnold; 2002.

14. [14] Choi S, Ki M. Estimating the reproductive number and the outbreak size of Novel Coronavirus disease (COVID-19) using mathematical model in Republic of Korea. Epidemiol Health 2020; e2020011. [DOI:10.4178/epih.e2020011] [PMID]

15. [15] Cao Z, Zhang Q, Lu X, Pfeiffer D, Jia Z, Song H, Zeng DD. Estimating the effective reproduction number of the 2019-nCoV in China. medRxiv 2020. [DOI:10.1101/2020.01.27.20018952]

16. [16] Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Internal Med 2020. [DOI:10.7326/M20-0504] [PMID] [PMCID]

17. [17] Liu Y, Yan LM, Wan L, Xiang TX, Le A, Liu JM, et al. Viral dynamics in mild and severe cases of COVID-19. The Lancet Infec Dis 2020. [DOI:10.1016/S1473-3099(20)30232-2]

18. [18] Ferguson N, Laydon D, Nedjati Gilani G, Imai N, Ainslie K, Baguelin M, et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. 2020.

19. [19] Colson P, Rolain JM, Lagier JC, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents 2020; 105932. [DOI:10.1016/j.ijantimicag.2020.105932] [PMID] [PMCID]

20. [20] Zhou D, Dai SM, Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chem 2020. [DOI:10.1093/jac/dkaa114] [PMID] [PMCID]

21. [21] Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess Cruise ship: A data-driven analysis. Int J Infect Dis 2020; 93: 201-204. [DOI:10.1016/j.ijid.2020.02.033] [PMID] [PMCID]

22. [22] Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Eng J Med 2020.

23. [23] Liu T, Hu J, Kang M, Lin L, Zhong H, Xiao J, He G, Song T, Huang Q, Rong Z. Transmission dynamics of 2019 novel coronavirus (2019-nCoV). 2020. [DOI:10.2139/ssrn.3526307]

24. [24] Abbott S, Hellewell J, Munday J, Funk S, group Cnw. The transmissibility of novel Coronavirus in the early stages of the 2019-20 outbreak in Wuhan: Exploring initial point-source exposure sizes and durations using scenario analysis. Well Open Res 2020; 5: 17. [DOI:10.12688/wellcomeopenres.15718.1] [PMID] [PMCID]

25. [25] Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S, et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect Dis 2020. [DOI:10.1101/2020.01.31.20019901]

26. [26] Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner NW, Ke R. The novel coronavirus, 2019-nCoV, is highly contagious and more infectious than initially estimated. arXiv preprint arXiv:200203268 2020. [DOI:10.1101/2020.02.07.20021154] [PMCID]

27. [27] Alimohamadi Y, Taghdir M, Sepandi M. The estimate of the basic reproduction number for novel coronavirus disease (COVID-19): a systematic review and meta-analysis. J Prevent Med Public Health 2020.

28. [28] Stein RA. Super-spreaders in infectious diseases. Int J Infect Dis 2011; 15: e510-e513. [DOI:10.1016/j.ijid.2010.06.020] [PMID] [PMCID]

29. [29] Hilton J, Keeling MJ. Estimation of country-level basic reproductive ratios for novel Coronavirus (COVID-19) using synthetic contact matrices. medRxiv 2020. [DOI:10.1101/2020.02.26.20028167]

30. [30] Shao N, Cheng J, Chen W. The reproductive number R0 of COVID-19 based on estimate of a statistical time delay dynamical system. medRxiv 2020. [DOI:10.1101/2020.02.17.20023747]

31. [31] Conyn-van Spaendonck MA, De Melker HE, Abbink F, Elzinga-Gholizadea N, Kimman TG, van Loon T. Immunity to poliomyelitis in The Netherlands. Am J Epidemiol 2001; 153: 207-214. [DOI:10.1093/aje/153.3.207] [PMID]

32. [32] Fine P, Eames K, Heymann DL. "Herd immunity": a rough guide. Clin Infect Dis 2011; 52: 911-916. [DOI:10.1093/cid/cir007] [PMID]

33. [33] Plans P, Torner N, Godoy P, Jane M. Lack of herd immunity against measles in individuals aged< 35 years could explain re-emergence of measles in Catalonia (Spain). Int J Infect Dis 2014; 18: 81-83. [DOI:10.1016/j.ijid.2013.09.015] [PMID]

34. [34] Murdoch DR, French NP. COVID-19: another infectious disease emerging at the animal-human interface. N Zealand Med J 2020; 133: 12.

35. [35] Ahmed SF, Quadeer AA, McKay MR. Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses 2020; 12: 254. [DOI:10.3390/v12030254] [PMID] [PMCID]

36. [36] Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, Russell TW, et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. The Lancet Global Health 2020. [DOI:10.1101/2020.02.08.20021162]

37. [37] Mukhtar F, Mukhtar N. Coronavirus (Covid-19): let's prevent not panic. J Ayub Med College Abbottabad 2020; 32